Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- Bacterial (2)
- Gene Expression Regulation (2)
- Inflammation (2)
- Obesity (2)
- 20-HETE regulation (1)
-
- 20-Hydroxyeicosatetraenoic acid (1)
- 3T3-L1 cells; Akt; PPARγ; adipogenesis; annual wormwood leaf; high-fat diet (1)
- ATPases (1)
- Abacavir; HIV infection; HLA-B*57:01; Hypersensitivity; Lamivudine (1)
- Acetyl Coenzyme A (1)
- Adipocytes drug effects and metabolism (1)
- Aedes virology (1)
- African Americans genetics (1)
- Aging; Geroprevention; Growth hormone; HSCs; Insulin; Insulin-like growth factor; Longevity; Parental imprinting; VSELs (1)
- Allopurinol therapeutic use (1)
- Alzheimer's disease (1)
- Amino acid sequence and substitution (1)
- Amyloid plaques (1)
- Analgesic tolerance (1)
- Angiotensiongen (1)
- Animals (1)
- Anti-HIV agents therapeutic use (1)
- Anti-obesity agents pharmacology (1)
- Antibodies (1)
- Antigens (1)
- Antimicrobial responses (1)
- Antineoplastic Combined Chemotherapy Protocols (1)
- Apoptosis (1)
- Apoptosis Regulatory Proteins (1)
- Autonomic Nervous System Diseases (1)
Articles 31 - 32 of 32
Full-Text Articles in Life Sciences
Benzylideneoxymorphone: A New Lead For Development Of Bifunctional Mu/Delta Opioid Receptor Ligands, Jason R. Healy, Padmavani Bezawada, Nicholas W. Griggs, Andrea L. Devereaux, Rae Reiko Matsumoto, John R. Traynor, Christopher W. Cunningham
Benzylideneoxymorphone: A New Lead For Development Of Bifunctional Mu/Delta Opioid Receptor Ligands, Jason R. Healy, Padmavani Bezawada, Nicholas W. Griggs, Andrea L. Devereaux, Rae Reiko Matsumoto, John R. Traynor, Christopher W. Cunningham
Faculty Publications & Research of the TUC College of Pharmacy
Opioid analgesic tolerance remains a considerable drawback to chronic pain management. The finding that concomitant administration of delta opioid receptor (DOR) antagonists attenuates the development of tolerance to mu opioid receptor (MOR) agonists has led to interest in producing bifunctional MOR agonist/DOR antagonist ligands. Herein, we present 7-benzylideneoxymorphone (6, UMB 246) displaying MOR partial agonist/DOR antagonist activity, representing a new lead for designing bifunctional MOR/DOR ligands.
Contributions Of Myd88-Dependent Receptors And Cd11c-Positive Cells To Corneal Epithelial Barrier Function Against Pseudomonas Aeruginosa, Matteo M. E. Metruccio, Connie Tam, David J. Evans, Anna L. Xie, Michael E. Stern, Suzanne M. J. Fleiszig
Contributions Of Myd88-Dependent Receptors And Cd11c-Positive Cells To Corneal Epithelial Barrier Function Against Pseudomonas Aeruginosa, Matteo M. E. Metruccio, Connie Tam, David J. Evans, Anna L. Xie, Michael E. Stern, Suzanne M. J. Fleiszig
Faculty Publications & Research of the TUC College of Pharmacy
Previously we reported that corneal epithelial barrier function against Pseudomonas aeruginosa was MyD88-dependent. Here, we explored contributions of MyD88-dependent receptors using vital mouse eyes and confocal imaging. Uninjured IL-1R (−/−) or TLR4 (−/−) corneas, but not TLR2 (−/−), TLR5 (−/−), TLR7 (−/−), or TLR9 (−/−), were more susceptible to P. aeruginosa adhesion than wild-type (3.8-fold, 3.6-fold respectively). Bacteria adherent to the corneas of IL-1R (−/−) or TLR5 (−/−) mice penetrated beyond the epithelial surface only if the cornea was superficially-injured. Bone marrow chimeras showed that bone marrow-derived cells contributed to IL-1R-dependent barrier function. In vivo, but not ex vivo …